Skip to main content
. 2015 Mar 25;28(2):523–539. doi: 10.1128/CMR.00124-14

FIG 3.

FIG 3

The future TB clinic. Sputum, saliva, and fecal samples are collected from patients for genome sequencing, SNP typing, or metagenomic profiling to identify the presence of M. tuberculosis; provide strain identification and epidemiological information; identify genetic susceptibility to drug toxicity, drug pharmacokinetics, and susceptibility to reactivation of latent TB; and describe the patient-specific microbiome and its potential for oral drug biotransformation after digestion.